Brief: India's Dr. Lal Pathlabs Sept-Qtr Consol Profit Rises
06/11/2018 08:58
Nov 6 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* SEPT QUARTER CONSOL NET PROFIT 570 MILLION RUPEES VERSUS
PROFIT
506 MILLION RUPEES YEAR AGO
* SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 3.18 BILLION
RUPEES
VERSUS 2.78 BILLION RUPEES YEAR AGO
* DECLARED INTERIM DIVIDEND OF 2.50 RUPEES PER SHARE
Source text - https://bit.ly/2P9fh3U
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise